1Cohen M, Sadhasivam S, Vinks AA. Pharmacogenetics in perioperative medicine. Curt Opin Anaesthesiol, 2012, 25 (4) :419-427.
2Borges S, Desta Z, Jin Y,et al. Composite functional genetic and comedication CYP2D6 activity score in predicting tamox- ifen drug exposure among breast cancer patients. J Clin Pharmacol, 2010,50 (4) : 450-458.
3Sadhasivam S, Myer CM 3rd. Preventing opioid-related deaths in children undergoing surgery. Pain Med, 2012 13 (7) ,982-983.
4Yuan R, Zhang X, Deng Q, et al. Impact of CYP3A4 1G polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery. Clin Chim Acta,2011, 412(9-10) 755-760.
5Gadeyne C, Van der Heyden S, Gasthuys F, et al. The in- fluence of modulation of P-glyeoprotein and/or cytochrome ]?450 3A on the pharmacokinetics and pharmacodynamics of orally ad ministered morphine in dogs. J Vet Pharmacol T- her, 2011,34(5) : 417-423.
6Frost J, Helland A, Nordrum IS, et al. Investigation of mor- phine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths. Forensic Sci Int, 2012,220(1-3) : 6-11.
7Ltsch J, Rohrbacher M, Schmidt H, et al. Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation? Pain, 2009,144(1-2) : 119-124.
8Kirchheiner J, Schrnidt H, Tzvetkov M, et al. Pharmacoki- netics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J,2007,7(4) :257-265.
9Ciszkowski C, Madadi P, Phillips MS, et al. Codeine, ultra- rapid-metabolism genotype, and postoperative death. N Engl J Med,2009,361(8) :827-828.
4Olivier T, Yvon L, Jean - Michel R, et al. Pharmaeogenomics [J]. Med Sci Monit, 2002; 8: 152-163.
5Ulrich MZ, Joachim F, Sebastian R, et al. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6 [J]. Pharmacogenetics, 2001; 11:573-585.
6Gan SH, Ismail R, Wan Adnan WA, et al. Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms [J]. J Clin Pharm Ther, 2004; 29:455-463.
7Stamer UM, Lehnen K, Hothker F, et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia [ J ]. Pain, 2003 ; 105 : 231 - 238.
8Pedersen RS, Damkier P, Brosen K. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study [J]. Clin Pharmacol Ther, 2005; 77:458-467.
9Leon DJ, Susce MT, Murray - Carmichael E. The AmpliChip CYP450 genotyping test: integrating a new clinical tool [ J ]. Mol Diagn Ther, 2006;10:135 - 151.
10Mizutani T. PM frequencies of major CYPs in Asians and Caucasians [J]. Drug Metab Rev, 2003; 35:99-106.
